Brii Biosciences and Joincare sign licence agreement for BRII-693
Brii Biosciences and the Joincare Pharmaceutical Group have signed a licence and technology transfer agreement for BRII-693, a new synthetic…
Infectious Diseases
-
-
Ligand’s LNHC concludes merger with CHRO
Ligand Pharmaceuticals’ wholly owned subsidiary LNHC has concluded its merger with Channel Therapeutics’ CHRO Merger Sub, resulting in the formation…
-
Analysis shows Yeztugo approval a ‘momentous step’ for HIV prevention
Gilead’s recently approved drug for HIV prevention, Yeztugo (lenacapavir), has the potential to transform the pre-exposure prophylaxis (PrEP) sector in…
-
WHO accuses China of withholding Covid-19 genetic data
The World Health Organization (WHO) says it is unable to concretely identify the origins of the virus that led to…
-
UK steps up with £1.25bn Gavi vaccine pledge as US funding disappears
The UK has confirmed its support for global vaccination by pledging £1.25bn to global vaccine group Gavi while the US…
-
UK and US governments pursue contrasting vaccine strategies
While the outlook for vaccines in the US looks bleak under the current administration, the UK Government is pressing ahead…
-
Ex-ACIP panel warns of ‘critically weakened’ US immunisation programme
Sweeping changes made by US health secretary Robert F Kennedy, Jr (RFK Jr) at the Centers for Disease Control and…
-
Vaccine sceptics among new members hired by RFK Jr for CDC’s vaccine panel
US Health Secretary Robert F Kennedy (RFK) Jr has appointed eight new members to the vaccine advisory panel at the…
-
Gilead hit with FDA clinical hold for batch of HIV trials
The US Food and Drug Administration (FDA) has placed a clinical hold on several of Gilead’s trials evaluating two HIV…
-
RFK Jr axes vaccine advisory committee members
The US department of Health and Human Services (HHS) has culled the 17 Biden-appointed members on the Advisory Committee for…
